Norah Sadek

1.1k total citations · 1 hit paper
7 papers, 624 citations indexed

About

Norah Sadek is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Norah Sadek has authored 7 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Norah Sadek's work include CAR-T cell therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Norah Sadek is often cited by papers focused on CAR-T cell therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Norah Sadek collaborates with scholars based in United States and United Kingdom. Norah Sadek's co-authors include Giorgos C. Karakousis, Ravi K. Amaravadi, Joshua D. Rabinowitz, Wei Xu, Wynetta Giles‐Davis, Meenhard Herlyn, Xiang Zhou, Ling Liu, Gao Zhang and Xiaowei Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Cell and Clinical Pharmacology & Therapeutics.

In The Last Decade

Norah Sadek

6 papers receiving 620 citations

Hit Papers

Enhancing CD8+ T Cell Fatty Acid Catabolism within a Meta... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norah Sadek United States 4 339 308 228 212 48 7 624
Alison Jaccard Switzerland 3 298 0.9× 237 0.8× 162 0.7× 85 0.4× 40 0.8× 4 485
Ihor Arkhypov Germany 10 402 1.2× 286 0.9× 228 1.0× 101 0.5× 71 1.5× 11 677
Chunyi Shen China 12 190 0.6× 232 0.8× 263 1.2× 149 0.7× 37 0.8× 17 533
Xenia Geeraerts Belgium 7 481 1.4× 255 0.8× 231 1.0× 89 0.4× 19 0.4× 12 668
Haofan Jin China 13 361 1.1× 345 1.1× 176 0.8× 62 0.3× 43 0.9× 25 681
Eveline M. Dijkgraaf Netherlands 5 406 1.2× 291 0.9× 149 0.7× 65 0.3× 31 0.6× 5 585
Ha Zhu China 10 304 0.9× 165 0.5× 305 1.3× 214 1.0× 14 0.3× 12 624
Madeline A. Hwee United States 3 330 1.0× 292 0.9× 217 1.0× 72 0.3× 46 1.0× 4 577
Romain Vuillefroy de Silly Switzerland 13 449 1.3× 236 0.8× 122 0.5× 66 0.3× 47 1.0× 15 635

Countries citing papers authored by Norah Sadek

Since Specialization
Citations

This map shows the geographic impact of Norah Sadek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norah Sadek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norah Sadek more than expected).

Fields of papers citing papers by Norah Sadek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norah Sadek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norah Sadek. The network helps show where Norah Sadek may publish in the future.

Co-authorship network of co-authors of Norah Sadek

This figure shows the co-authorship network connecting the top 25 collaborators of Norah Sadek. A scholar is included among the top collaborators of Norah Sadek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norah Sadek. Norah Sadek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Costa, Bruno Almeida, Danai Dima, Tomer M. Mark, et al.. (2025). Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis. Journal of Clinical Medicine. 14(4). 1316–1316.
2.
Dima, Danai, Adriana Rossi, Tomer M. Mark, et al.. (2024). P-408 Survival Analysis of Selinexor-Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Real-World Exploratory Analysis. Clinical Lymphoma Myeloma & Leukemia. 24. S270–S270. 1 indexed citations
3.
Sadek, Norah, Bruno Almeida Costa, Karthik Nath, & Sham Mailankody. (2023). CAR T‐Cell Therapy for Multiple Myeloma: A Clinical Practice‐Oriented Review. Clinical Pharmacology & Therapeutics. 114(6). 1184–1195. 9 indexed citations
4.
Upadhyay, Ranjan, Jonathan Boiarsky, Judit Svensson‐Arvelund, et al.. (2021). A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy. Cancer Discovery. 11(3). 599–613. 125 indexed citations
5.
Boiarsky, Jonathan, Ranjan Upadhyay, Judit Svensson‐Arvelund, et al.. (2020). 90 Potentiation of T-cell mediated tumor killing via modulation of the fas/fasL pathway. SHILAP Revista de lepidopterología. A57–A58. 1 indexed citations
6.
Zhang, Ying, Raj K. Kurupati, Ling Liu, et al.. (2017). Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy. Cancer Cell. 32(3). 377–391.e9. 481 indexed citations breakdown →
7.
Metcalfe, David, Sidhartha Sinha, Norah Sadek, et al.. (2013). Successful Use of Talc Sclerodesis to Control a Persistent High-Output Groin Seroma Following Endovascular Abdominal Aortic Aneurysm Repair. Annals of Vascular Surgery. 27(6). 801.e9–801.e12. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026